• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Prevalence of Erectile Dysfunction in Malagasy Patients With Diabetes Mellitus and Its Associations With Atherosclerotic Cardiovascular Diseases: A Cross-Sectional Study.马达加斯加糖尿病患者勃起功能障碍的患病率及其与动脉粥样硬化性心血管疾病的关联:一项横断面研究。
Endocrinol Diabetes Metab. 2025 Sep;8(5):e70098. doi: 10.1002/edm2.70098.
2
Non-invasive positive airway pressure therapy for improving erectile dysfunction in men with obstructive sleep apnoea.无创正压通气治疗阻塞性睡眠呼吸暂停男性勃起功能障碍。
Cochrane Database Syst Rev. 2021 Sep 23;9(9):CD013169. doi: 10.1002/14651858.CD013169.pub2.
3
Psychosocial interventions for erectile dysfunction.勃起功能障碍的心理社会干预措施。
Cochrane Database Syst Rev. 2007 Jul 18;2007(3):CD004825. doi: 10.1002/14651858.CD004825.pub2.
4
Primary Research on Correlation between Erectile Function Assessment through International Index of Erectile Function Score and Nocturnal Penile Tumescence and Rigidity Measurements in Men with Erectile Dysfunction.国际勃起功能指数评分评估勃起功能与勃起功能障碍男性夜间阴茎勃起及硬度测量之间相关性的初步研究
F1000Res. 2025 Jul 30;14:142. doi: 10.12688/f1000research.149499.2. eCollection 2025.
5
Coronary artery calcium, hepatic steatosis, and atherosclerotic cardiovascular disease risk in patients with type 2 diabetes mellitus: Results from the Dallas heart study.2 型糖尿病患者的冠状动脉钙、肝脂肪变性和动脉粥样硬化性心血管疾病风险:达拉斯心脏研究的结果。
Prog Cardiovasc Dis. 2023 May-Jun;78:67-73. doi: 10.1016/j.pcad.2023.03.002. Epub 2023 Mar 15.
6
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂在患有早期(1 至 3 期)非糖尿病慢性肾脏病的成人中的应用。
Cochrane Database Syst Rev. 2023 Jul 19;7(7):CD007751. doi: 10.1002/14651858.CD007751.pub3.
7
Beta-blockers for hypertension.用于治疗高血压的β受体阻滞剂。
Cochrane Database Syst Rev. 2017 Jan 20;1(1):CD002003. doi: 10.1002/14651858.CD002003.pub5.
8
Association Between Opioid Use and Risk of Erectile Dysfunction: A Systematic Review and Meta-Analysis.阿片类药物使用与勃起功能障碍风险的关联:系统评价和荟萃分析。
J Sex Med. 2017 Oct;14(10):1209-1219. doi: 10.1016/j.jsxm.2017.08.010. Epub 2017 Sep 8.
9
Association Between HIV Infection and Prevalence of Erectile Dysfunction: A Systematic Review and Meta-Analysis.HIV感染与勃起功能障碍患病率之间的关联:一项系统评价和荟萃分析。
J Sex Med. 2017 Sep;14(9):1125-1132. doi: 10.1016/j.jsxm.2017.07.001. Epub 2017 Aug 1.
10
Low-intensity shockwave therapy for erectile dysfunction.低强度冲击波疗法治疗勃起功能障碍
Cochrane Database Syst Rev. 2025 Jul 14;7:CD013166. doi: 10.1002/14651858.CD013166.pub3.

本文引用的文献

1
Relationship Between Hypertension, Antihypertensive Drugs and Sexual Dysfunction in Men and Women: A Literature Review.高血压、降压药与男女性功能障碍的关系:文献综述。
Vasc Health Risk Manag. 2023 Nov 3;19:691-705. doi: 10.2147/VHRM.S439334. eCollection 2023.
2
Magnitude of erectile dysfunction and associated factors among adult diabetic men on follow-up at Goba and Robe hospitals, Bale Zone, South East Ethiopia: hospital-based cross-sectional study.埃塞俄比亚东南伯勒地区戈巴和罗贝医院随访成年糖尿病男性勃起功能障碍的严重程度及其相关因素:基于医院的横断面研究。
BMC Endocr Disord. 2023 Oct 26;23(1):236. doi: 10.1186/s12902-023-01489-x.
3
Association of erectile dysfunction with coronary artery disease in Type 2 Diabetes mellitus.2 型糖尿病患者勃起功能障碍与冠状动脉疾病的相关性。
Ghana Med J. 2023 Jan;57(1):43-48. doi: 10.4314/gmj.v57i1.7.
4
Erectile dysfunction and associated factors among patients with diabetes attending follow-up at a public hospital, Harar, Eastern Ethiopia. A cross-sectional study design.在埃塞俄比亚东部哈拉尔的一家公立医院接受随访的糖尿病患者的勃起功能障碍及其相关因素。一项横断面研究设计。
Front Endocrinol (Lausanne). 2023 Jun 13;14:1131555. doi: 10.3389/fendo.2023.1131555. eCollection 2023.
5
Genetically predicted hypertension, antihypertensive drugs, and risk of erectile dysfunction: a Mendelian randomization study.基因预测的高血压、抗高血压药物与勃起功能障碍风险:一项孟德尔随机化研究
Front Cardiovasc Med. 2023 Jun 9;10:1157467. doi: 10.3389/fcvm.2023.1157467. eCollection 2023.
6
An overview of the history, current strategies, and potential future treatment approaches in erectile dysfunction: a comprehensive review.勃起功能障碍的历史、当前策略和潜在未来治疗方法概述:全面综述。
Sex Med Rev. 2023 Jun 27;11(3):253-267. doi: 10.1093/sxmrev/qead014.
7
Diabetes and erectile dysfunction: The relationships with health literacy, treatment adherence, unrealistic optimism, and glycaemic control.糖尿病与勃起功能障碍:与健康素养、治疗依从性、不切实际的乐观态度及血糖控制的关系。
Diabetes Metab Res Rev. 2023 Jul;39(5):e3629. doi: 10.1002/dmrr.3629. Epub 2023 Mar 3.
8
Prevalence of erectile dysfunction in Type 2 diabetes mellitus (T2DM) and its predictors among diabetic men.2型糖尿病(T2DM)男性患者勃起功能障碍的患病率及其预测因素
J Family Med Prim Care. 2022 Jul;11(7):3875-3879. doi: 10.4103/jfmpc.jfmpc_1130_21. Epub 2022 Jul 22.
9
Analysis of the Factors Associated With ED in Type 2 Diabetics at the University Hospital of Libreville.利伯维尔大学医院2型糖尿病患者勃起功能障碍相关因素分析
Sex Med. 2022 Dec;10(6):100564. doi: 10.1016/j.esxm.2022.100564. Epub 2022 Sep 17.
10
Prevalence and associated factors of erectile dysfunction in men with type 2 diabetes mellitus in eastern Sudan.苏丹东部 2 型糖尿病男性勃起功能障碍的患病率及相关因素。
BMC Endocr Disord. 2022 May 28;22(1):141. doi: 10.1186/s12902-022-01060-0.

马达加斯加糖尿病患者勃起功能障碍的患病率及其与动脉粥样硬化性心血管疾病的关联:一项横断面研究。

Prevalence of Erectile Dysfunction in Malagasy Patients With Diabetes Mellitus and Its Associations With Atherosclerotic Cardiovascular Diseases: A Cross-Sectional Study.

作者信息

Raharinavalona Sitraka Angelo, Ranjandriarison Tafitarilova Dorland, Razanamparany Thierry, Randriamahavonjy Romuald, Rakotomalala Andrianirina Dave Patrick

机构信息

Cardiovascular Diseases and Internal Medicine Department, Soavinandriana Hospital Center, Antananarivo, Madagascar.

Obstetrics and Gynecology Department, Soavinandriana Hospital Center, Antananarivo, Madagascar.

出版信息

Endocrinol Diabetes Metab. 2025 Sep;8(5):e70098. doi: 10.1002/edm2.70098.

DOI:10.1002/edm2.70098
PMID:40852744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12375927/
Abstract

OBJECTIVES

Our study aims to determine the prevalence of erectile dysfunction (ED) and its associations with atherosclerotic cardiovascular disease (ASCVD) in Malagasy patients with diabetes mellitus (DM).

METHODS

This cross-sectional study was conducted over a period of 3 years at the Soavinandriana Hospital Center. Erectile function was assessed using the International Index of Erectile Function 5-item version (IIEF-5) questionnaire, with a score of less than 22 indicating ED. The presence of ASCVD was confirmed in cases where carotid atherosclerosis (CAS), lower limb arteriopathy (LLA), coronary heart disease (CHD) and/or ischaemic stroke were present.

RESULTS

The study population included 305 patients diagnosed with diabetes mellitus (DM). The prevalence of erectile dysfunction (ED) was 73.4%. According to the bivariate analysis, the risk factors for ED were age ≥ 55 years (odds ratio [OR] 12.0 (6.34-23.4)), hypertension (OR 6.02 (3.27-11.3)), physical inactivity (OR 8.86 (4.85-16.6)), smoking (OR 2.53 (1.32-5.09)), dyslipidemia (OR 4.11 (2.33-7.32)), type 2 DM (OR 8.80 (1.53-91.0)) and diabetes duration ≥ 10 years (OR 2.24 (1.11-4.87)), renin-angiotensin-aldosterone system blockers (OR 6.27 (3.43-11.6)), calcium-channel blockers (OR 3.01 (1.69-5.48)), diuretics (OR 2.14 (1.06-4.66)) and beta-blockers (OR 4.55 (1.85-13.5)). After adjusting for age, hypertension, physical inactivity, smoking and dyslipidemia, ED was significantly associated with ASCVD (OR 1.88 (1.01-3.69)), and CAS (OR 1.89 (1.03-3.22)). Adjusting for age, type and duration of DM, ED was found to be significantly associated with ASCVD (OR 1.91 (1.01-3.58)) and CAS (OR 2.31 (1.11-4.85)). However, there was no statistically significant association between ED, LLA, CHD and ischaemic stroke.

CONCLUSION

ED was very common and may be a predictor of ASCVD in patients with DM, particularly CAS. Consequently, the presence of ED should prompt the search for ASCVD, and vice versa.

摘要

目的

我们的研究旨在确定马达加斯加糖尿病(DM)患者勃起功能障碍(ED)的患病率及其与动脉粥样硬化性心血管疾病(ASCVD)的关联。

方法

这项横断面研究在索阿维南德里亚纳医院中心进行了3年。使用国际勃起功能指数5项版本(IIEF-5)问卷评估勃起功能,得分低于22表明存在ED。在存在颈动脉粥样硬化(CAS)、下肢动脉病变(LLA)、冠心病(CHD)和/或缺血性卒中的情况下确认存在ASCVD。

结果

研究人群包括305例诊断为糖尿病(DM)的患者。勃起功能障碍(ED)的患病率为73.4%。根据双变量分析,ED的危险因素为年龄≥55岁(比值比[OR]12.0(6.34 - 23.4))、高血压(OR 6.02(3.27 - 11.3))、身体活动不足(OR 8.86(4.85 - 16.6))、吸烟(OR 2.53(1.32 - 5.09))、血脂异常(OR 4.11(2.33 - 7.32))、2型DM(OR 8.80(1.53 - 91.0))和糖尿病病程≥10年(OR 2.24(1.11 - 4.87))、肾素 - 血管紧张素 - 醛固酮系统阻滞剂(OR 6.27(3.43 - 11.6))、钙通道阻滞剂(OR 3.01(1.69 - 5.48))、利尿剂(OR 2.14(1.06 - 4.66))和β受体阻滞剂(OR 4.55(1.85 - 13.5))。在调整年龄、高血压、身体活动不足、吸烟和血脂异常后,ED与ASCVD(OR 1.88(1.01 - 3.69))和CAS(OR 1.89(1.03 - 3.22))显著相关。在调整DM的年龄、类型和病程后,发现ED与ASCVD(OR 1.91(1.01 - 3.58))和CAS(OR 2.31(1.11 - 4.85))显著相关。然而,ED与LLA、CHD和缺血性卒中之间没有统计学上的显著关联。

结论

ED非常常见,可能是DM患者ASCVD的预测指标,尤其是CAS。因此,ED的存在应促使对ASCVD的筛查,反之亦然。